Cray (NASDAQ: CRAY) 22.1% HIGHER; reported Q3 EPS of $0.48, $0.42 better than the analyst estimate of $0.06. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Margin Pressures Could Weigh on CVS Health (CVS) Shares; Oppenheimer Cuts Price Target to $115 November 2, 2015 11:16 AM Leerink Partners Would Buy CVS Health (CVS) on Current Weakness October 30, 2015 1:39 PM Cowen Cuts Price Target on SolarCity (SCTY) Following 3Q EPS Miss October 30, 2015 10:34 AM Growth Drivers Set For LinkedIn's (LNKD) 2016; SunTrust Robinson Humphrey Raises Price Target to $280 October 30, 2015 10:21 AM Bill Ackman said Valeant Pharma (VRX) worth $180-$240 Near-Term, $262-$350 Long-TermOctober 30, 2015 10:14 AM Evercore ISI Reiterates Hold Following Expedia's (EXPE) 3Q October 30, 2015 10:13 AM Evercore ISI Raises Price target on LinkedIn (LNKD) to $235 Following 3Q October 30, 2015 10:05 AM RBC Capital Raises Price Target on Expedia (EXPE) Following 3Q Earnings Results October 30, 2015 9:57 AM Needham & Company Raises Price Target on Cray (CRAY) to $35 Following a 42c EPS Beat October 30, 2015 9:42 AM Sterne Agee CRT Sees Deckers Outdoor (DECK) 3Q Guidance as 'Best Case' Scenario; Maintains Neutral Rating October 30, 2015 9:34 AM LendingClub (LC) Reports Good 3Q Beat; Compass Point Maintains a Sell Rating October 30, 2015 9:26 AM LinkedIn (LNKD) Reports Upside to 3Q; Needham & Company Reiterates Buy October 30, 2015 9:08 AM Cowen Cuts Price Target on Control4 (CTRL) Following 3Q Growth Issues October 30, 2015 9:00 AM First Solar (FSLR) Reported a Strong EPS Beat in 3Q; Baird Reiterates Outperform October 30, 2015 7:59 AM First Solar (FSLR) Sells Majority Interest in Desert Stateline Project; Needham & Company Reiterates Buy October 30, 2015 6:51 AM